NM_000350.3:c.6316C>T
Variant summary
Our verdict is Pathogenic. The variant received 17 ACMG points: 17P and 0B. PM1PM5PP2PP3_StrongPP5_Very_Strong
The NM_000350.3(ABCA4):c.6316C>T(p.Arg2106Cys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000985 in 1,614,108 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R2106H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000350.3 missense
Scores
Clinical Significance
Conservation
Publications
- ABCA4-related retinopathyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- cone-rod dystrophy 3Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Ambry Genetics
- severe early-childhood-onset retinal dystrophyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Laboratory for Molecular Medicine, Labcorp Genetics (formerly Invitae), Ambry Genetics
- retinitis pigmentosa 19Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
- cone-rod dystrophyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- retinitis pigmentosaInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- Stargardt diseaseInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 17 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.000302  AC: 46AN: 152178Hom.:  0  Cov.: 33 show subpopulations 
GnomAD2 exomes  AF:  0.0000995  AC: 25AN: 251238 AF XY:  0.0000957   show subpopulations 
GnomAD4 exome  AF:  0.0000773  AC: 113AN: 1461812Hom.:  0  Cov.: 33 AF XY:  0.0000715  AC XY: 52AN XY: 727198 show subpopulations 
Age Distribution
GnomAD4 genome  0.000302  AC: 46AN: 152296Hom.:  0  Cov.: 33 AF XY:  0.000336  AC XY: 25AN XY: 74478 show subpopulations 
Age Distribution
ClinVar
Submissions by phenotype
not provided    Pathogenic:3Other:1 
- -
In silico analysis, which includes protein predictors and evolutionary conservation, supports a deleterious effect; This variant is associated with the following publications: (PMID: 11379881, 9054934, 23143460, 25066811, 28044389, 28355279, 25283059, 30903310, 34426522, 31589614, 29114839, 32619608) -
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 2106 of the ABCA4 protein (p.Arg2106Cys). This variant is present in population databases (rs61750648, gnomAD 0.08%). This missense change has been observed in individual(s) with Stargardt disease (PMID: 11379881, 23143460, 25283059, 28355279). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 99447). Invitae Evidence Modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) indicates that this missense variant is expected to disrupt ABCA4 protein function with a positive predictive value of 95%. Experimental studies have shown that this missense change affects ABCA4 function (PMID: 11017087). This variant disrupts the p.Arg2106 amino acid residue in ABCA4. Other variant(s) that disrupt this residue have been observed in individuals with ABCA4-related conditions (PMID: 26161775, 28327576), which suggests that this may be a clinically significant amino acid residue. For these reasons, this variant has been classified as Pathogenic. -
- -
Retinal dystrophy    Pathogenic:3 
- -
- -
- -
Age related macular degeneration 2    Pathogenic:1 
Criteria applied: PM3_VSTR,PM5,PM2_SUP,PP3 -
ABCA4-related retinopathy    Pathogenic:1 
- -
Severe early-childhood-onset retinal dystrophy    Pathogenic:1 
- -
Stargardt disease    Pathogenic:1 
The p.Arg2106Cys variant in ABCA4 has been reported in at least 5 individuals (compound heterozygotes) with Stargardt disease (Allikmets 1997, Zernant 2011, Downes 2012, Zernant 2014, Schulz 2017). This variant has also been identified in 0.04% (4/10392) of African chromosomes by the Exome Aggregation Consortium (ExAC, http://exac.broadinstitute.org; dbSNP rs61750648). Although this variant has been seen in the general population, its frequency is low enough to be consistent with a recessive carrier frequency. Computational prediction tools and conservation analysis are consistent with pathogenicity. In summary, this variant meets criteria to be classified as pathogenic for Stargardt disease in an autosomal recessive manner based upon case studies and low frequency in controls. -
Retinitis pigmentosa    Pathogenic:1 
ACMG/AMP guidelines: PM2, PP3, PM5, PP1, PM3_PS -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at